Skip to main content

Advertisement

SpringerLink
Log in

Association of polymorphisms in interleukin-18 and interleukin-28B genes with outcomes of hepatitis B virus infections: a meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

Several polymorphisms in the interleukin-18 (IL-18) and nterleukin-28B (IL-28B) genes have been reported to influence hepatitis B virus (HBV) infection. However, the published findings have been conflicting. We conducted meta-analyses of randomized, controlled trials to address the association of IL-18 or IL-28B polymorphisms and the outcomes of HBV infection. Weipu, Wanfang, CNKI, MEDLINE, PubMed, EMBASE, and Cochrane Library databases were employed to search for citations using the MeSH terms as “interleukin-18”/“interleukin-28B” AND “HBV” AND “gene” AND “polymorphism” without any restriction in language and publication year. Meta-analysis was conducted by RevMan 5.0 software. The results showed that the IL28B rs8099917 AA genotype (AA vs AC + CC: odds ratio (OR) = 0.63, 95 % confidence interval (CI) = 0.46–0.87) was associated with a decreased risk of hepatocellular carcinoma (HCC). Carriage of IL28B rs12979860 CC genotype was associated with an increased risk for developing liver cirrhosis among patients with HBV infection (CC vs CT + TT: OR = 1.39, 95 % CI = 1.04–1.85). Further well-designed large studies are warranted to confirm the mechanisms by which these are involved in these outcomes of HBV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Maddrey WC. Hepatitis B: an important public health issue. J Med Virol. 2000;61:362–6.

    Article  CAS  PubMed  Google Scholar 

  2. Lee WM. Hepatitis B, virus infection. N Engl J Med. 1997;337:1733–45.

    Article  CAS  PubMed  Google Scholar 

  3. Chen CJ, Wang LY, Yu MW. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol. 2000;15:E3–6.

    Article  PubMed  Google Scholar 

  4. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis. 2002;2:479–86.

    Article  PubMed  Google Scholar 

  5. Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Sem Liver Dis. 1991;11:84–92.

    Article  CAS  Google Scholar 

  6. Lavanchy D. Hepatitis B, virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97–107.

    Article  CAS  PubMed  Google Scholar 

  7. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009;49:S45–55.

    Article  CAS  PubMed  Google Scholar 

  8. Liu YZ, Hou FQ, Ding P, Ren YY, Li SH, Wang GQ. Pegylated interferon α enhances recovery of memory T cells in e antigen positive chronic hepatitis B patients. Virol J. 2012;9:274.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Chen L, Liu WQ, Lei JH, Guan F, Li MJ, Song WJ, et al. Chronic Schistosoma japonicum infection reduces immune response to vaccine against hepatitis B in mice. PLoS One. 2012;7:e51512.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Ben-Ari Z, Mor E, Papo O, Kfir B, Sulkes J, Tambur AR, et al. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol. 2003;98:144–50.

    Article  CAS  PubMed  Google Scholar 

  11. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009;461:399–401.

    Article  CAS  PubMed  Google Scholar 

  12. Balagopal A, Thomas DL, Thio CL. IL28B and the control of hepatitis C virus infection. Gastroenterology. 2010;139:1865–76.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Li W, Jiang Y, Jin Q, Shi X, Jin J, Gao Y, et al. Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population. Liver Int. 2011;31:1118–26.

    Article  CAS  PubMed  Google Scholar 

  14. Peng LJ, Guo JS, Zhang Z, Shi H, Wang J, Wang JY. IL28B rs12979860 polymorphism does not influence outcomes of hepatitis B virus infection. Tissue Antigens. 2012;79:302–5.

    Article  CAS  PubMed  Google Scholar 

  15. Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol. 2002;76:10702–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Tanaka-Kataoka M, Kunikata T, Takayama S, Iwaki K, Ohashi K, Ikeda M, et al. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection. Cytokine. 1999;11:593–9.

    Article  CAS  PubMed  Google Scholar 

  17. Sun Y, Chen HY, Xin SJ. Effect of IL-18 on peripheral blood mononuclear cells of chronic hepatitis B and hepatitis B virus DNA released by HepG2.2.15 cell lines. Hepatobiliary Pancreat Dis Int. 2004;3:230–4.

    CAS  PubMed  Google Scholar 

  18. Kim YS, Cheong JY, Cho SW, Lee KM, Hwang JC, Oh B, et al. A functional SNP of the Interleukin-18 gene is associated with the presence of hepatocellular carcinoma in hepatitis B virus-infected patients. Dig Dis Sci. 2009;54:2722–8.

    Article  CAS  PubMed  Google Scholar 

  19. Higa S, Hirano T, Mayumi M, Hiraoka M, Ohshima Y, Nambu M, et al. Association between interleukin-18 gene polymorphism 105A/C and asthma. Clin Exp Allergy. 2003;33:1097–102.

    Article  CAS  PubMed  Google Scholar 

  20. Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol. 2001;112:146–52.

    Article  CAS  PubMed  Google Scholar 

  21. Khripko OP, Sennikova NS, Lopatnikova JA, Khripko JI, Filipenko ML, Khrapov EA, et al. Association of single nucleotide polymorphisms in the IL-18 gene with production of IL-18 protein by mononuclear cells from healthy donors. Mediators Inflamm. 2008;309721.

  22. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.

    Article  CAS  PubMed  Google Scholar 

  23. Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2005;28:123–37.

    Article  PubMed  Google Scholar 

  24. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in metaanalyses. BMJ. 2003;327:557–60.

    Article  PubMed  Google Scholar 

  25. Pereira TV, Rudnicki M, Cheung BM, Baum L, Yamada Y, Oliveira PS, et al. Three endothelial nitric oxide (NOS3) gene polymorphisms in hypertensive and normotensive individuals: meta-analysis of 53 studies reveals evidence of publication bias. J Hypertens. 2007;25:1763–74.

    Article  CAS  PubMed  Google Scholar 

  26. Hirankarn N, Manonom C, Tangkijvanich P, Poovorawan Y. Association of interleukin-18 gene polymorphism (–607A/A genotype) with susceptibility to chronic hepatitis B virus infection. Tissue Antigens. 2007;70:160–3.

    Article  CAS  PubMed  Google Scholar 

  27. Cheong JY, Cho SW, Oh B, Kimm K, Lee KM, Shin SJ, et al. Association of interleukin-18 gene polymorphisms with hepatitis B virus clearance. Dig Dis Sci. 2010;55:1113–9.

    Article  CAS  PubMed  Google Scholar 

  28. Zhang PA, Wu JM, Li Y, Yang XS. Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population. World J Gastroenterol. 2005;11:1594–8.

    CAS  PubMed  Google Scholar 

  29. Migita K, Sawakami-Kobayashi K, Maeda Y, Nakao K, Kondoh S, Sugiura M, et al. Interleukin-18 promoter polymorphisms and the disease progression of hepatitis B virus-related liver disease. Transl Res. 2009;153:91–6.

    Article  CAS  PubMed  Google Scholar 

  30. Chen Q, Liao WJ, He SQ, Yuan SG, Qin LL, Yu YQ, et al. The correlation between single nucleotide polymorphism of interleukin-18 gene promoter and genetic susceptibility to hepatocellular carcinoma. Immunol J. 2012;28:1051–5 [Article in Chinese].

    CAS  Google Scholar 

  31. Li N, Gao YF, Zhang TC, Chen P, Li X, Su F. Relationship between interleukin 18 polymorphisms and susceptibility to chronic hepatitis B virus infection. World J Hepatol. 2012;4:105–9.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Gao JM, Zou YL, Dong H, Tang H, Xu Y, Yan XM. Relationship between HBV infection and polymorphism of IL-18 promoter gene among three minority populations in Yunnan province. Chin J Clin. 2010;4:1525–31 [Article in Chinese].

    Google Scholar 

  33. Chen J, Wang L, Li Y, Cai B, Fu Y, Liao Y, et al. Association analysis between SNPs in IL-28B gene and the progress of hepatitis B infection in Han Chinese. PLoS One. 2012;7(12):e50787.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Ren S, Lu J, Du X, Huang Y, Ma L, Huo H, et al. Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma. Cancer Immunol Immunother. 2012;61:1433–9.

    Article  CAS  PubMed  Google Scholar 

  35. Martin MP, Qi Y, Goedert JJ, Hussain SK, Kirk GD, Hoots WK, et al. IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection. J Infect Dis. 2010;202:1749–53.

    Article  CAS  PubMed  Google Scholar 

  36. Martín-Carbonero L, Rallón NI, Benito JM, Poveda E, González-Lahoz J, Soriano V. Does interleukin-28B single nucleotide polymorphisms influence the natural history of hepatitis B? AIDS Res Hum Retroviruses. 2012;28:1262–4.

    Article  PubMed  Google Scholar 

  37. Wang Y, Zhang HH, Chen YH, Xie XW, Liao WJ, Qin LL, et al. Correlation between interleukin-28B genetic polymorphisms and primary hepatocellular carcinoma. Zhonghua Yu Fang Yi Xue Za Zhi. 2012;46:527–32 [Article in Chinese].

    CAS  PubMed  Google Scholar 

  38. Jiao XL, Gao YT, Jing L, Liu T, Shi WX, Guo H, et al. Studies on the relationship between polymorphism of IL-28B rs8099917 and the outcome of HBV infection. Zhonghua Liu Xing Bing Xue Za Zhi. 2011;32:1143–7 [Article in Chinese].

    CAS  PubMed  Google Scholar 

  39. Fabris C, Falleti E, Cussigh A, Bitetto D, Fontanini E, Bignulin S, et al. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC. J Hepatol. 2011;54:716–22.

    Article  CAS  PubMed  Google Scholar 

  40. Dunford L, Carr MJ, Dean J, Nguyen LT, Ta Thi TH, Nguyen BT, et al. A multicentre molecular analysis of hepatitis B and blood-borne virus coinfections in Viet Nam. PLoS One. 2012;7:e39027.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  41. Holmes JA, Nguyen T, Ratnam D, Heerasing NM, Tehan JV, Bonanzinga S, et al. IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α. J Gastroenterol Hepatol. 2013;28:861–6.

    Article  CAS  PubMed  Google Scholar 

  42. Lee IC, Lin CH, Huang YH, Huo TI, Su CW, Hou MC, et al. IL28B polymorphism correlates with active hepatitis in patients with HBeAg-negative chronic hepatitis B. PLoS One. 2013;8:e58071.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  43. Sonneveld MJ, Wong VW, Wotman AM, Wong GLH, Buster EHCJ, Hansen BE, et al. Polymorphisms at rs12979860 and rs12980275 near IL28B predict serological response to (Peg)-interferon in HBeAg-positive chronic hepatitis B. J Hepatol. 2011;54:S32.

    Article  Google Scholar 

Download references

Acknowledgments

The authors appreciate the thoughtful advice of Wei Wang (China Medical University).

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Biochemistry and Molecular Biology, School of Basic Medical Science, China Medical University, Shenyang, 110001, Liaoning, People’s Republic of China

    Pu Xia

  2. Medical Laboratory Technology Center, China Medical University, Shenyang, People’s Republic of China

    Mo Zhou

  3. Department of Anaesthesiology, First Affiliated Hospital, China Medical University, Shenyang, People’s Republic of China

    Dao Song Dong

  4. Department of Surgical Oncology, First Affiliated Hospital, China Medical University, Shenyang, People’s Republic of China

    Ya-Nan Xing

  5. Department of Clinical Pharmacology, College of Pharmacy, China Medical University, Shenyang, People’s Republic of China

    Yang Bai

Authors
  1. Pu Xia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mo Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dao Song Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ya-Nan Xing
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yang Bai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pu Xia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xia, P., Zhou, M., Dong, D.S. et al. Association of polymorphisms in interleukin-18 and interleukin-28B genes with outcomes of hepatitis B virus infections: a meta-analysis. Tumor Biol. 35, 1129–1137 (2014). https://doi.org/10.1007/s13277-013-1151-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1151-y

Keywords

Search

Navigation